|1.||Jose, Pedro A: 33 articles (01/2015 - 03/2002)|
|2.||Felder, Robin A: 18 articles (01/2013 - 03/2002)|
|3.||Eisner, Gilbert M: 15 articles (06/2010 - 03/2002)|
|4.||Zeng, Chunyu: 14 articles (01/2015 - 03/2004)|
|5.||Asico, Laureano D: 12 articles (01/2015 - 03/2002)|
|6.||Bezard, Erwan: 11 articles (06/2015 - 11/2004)|
|7.||Armando, Ines: 11 articles (08/2013 - 06/2006)|
|8.||Luedtke, Robert R: 10 articles (01/2015 - 09/2004)|
|9.||Ferone, Diego: 10 articles (02/2014 - 05/2004)|
|10.||Wang, Xiaoyan: 9 articles (01/2015 - 04/2005)|
|1.||Schizophrenia (Dementia Praecox)
10/01/1995 - "Laboratory and clinical findings have led to a hypothesis that antagonism of 5-HT2A receptors in the brain limits the undesirable motor side effects associated with dopamine receptor blockade and improves efficacy against the negative symptoms of schizophrenia. "
06/22/2015 - "Nonetheless, studies point out a link between retinoid dysregulation and schizophrenia through modulation of dopamine receptors. "
01/01/2015 - "Preclinical studies suggest that D3 versus D2 dopamine receptor selective compounds might represent an alternative strategy for the treatment of the symptoms of schizophrenia. "
06/01/2014 - "Our study reviews the classification, genetic structure of dopamine receptors and the recent pertinent studies between the dopamine receptors and schizophrenia and its forensic significance."
04/01/2013 - "Previous studies have reported significant associations between schizophrenia and the dopamine receptor D2 gene (DRD2) variants. "
|2.||Parkinson Disease (Parkinson's Disease)
01/01/1977 - "The rotating rodent is an animal model commonly used to study the phenomenon of striatal dopamine receptor supersensitivity, and to investigate drugs which may prove to be beneficial in the treatment of Parkinson's disease. "
05/01/2012 - "Dopamine receptor-mediated inhibition of polysynaptic connections in the STN might be beneficial in the treatment of Parkinson's disease."
04/10/2012 - "In the present study, we used human brain samples to examine the relationship between CB₁R and dopamine receptor density in case of Parkinson's disease (PD). "
09/01/2006 - "What has been learnt from study of dopamine receptors in Parkinson's disease?"
11/01/2004 - "Role of dopaminergic treatment in dopamine receptor down-regulation in advanced Parkinson disease: a positron emission tomographic study."
|3.||Psychotic Disorders (Schizoaffective Disorder)
01/01/2003 - "Chronic use of dopamine receptor blocking agents should be limited as much as possible to patients with chronic psychoses. "
01/01/2001 - "[Dopamine receptor gene (DRD2) polymorphism in patients with endogenous psychoses with regard to their clinical heterogeneity]."
05/01/2000 - "Dopamine receptor D2 Ser/Cys 311 variant is associated with delusion and disorganization symptomatology in major psychoses."
10/15/1999 - "Dopamine receptor D4 gene is not associated with major psychoses."
10/15/1999 - "Previously, we reported an association of the dopamine receptor D4 (DRD4) gene with delusional symptomatology of major psychoses. "
|4.||Movement Disorders (Movement Disorder)
01/01/2013 - "Based upon these results we propose that SV 293 is a useful pharmacological tool that can be used for both in vitro and in vivo studies to investigate the role of D2-like dopamine receptor subtypes in neurological, neuropsychiatric and movement disorders where dopaminergic pathways have been implicated. "
01/05/2010 - "To elucidate a widely suspected but inconclusive association between rs6280 in the dopamine receptor 3 gene (DRD3) and prevalence of tardive dyskinesia (TD), we conducted a meta-analysis of studies obtained in a systematic search of several bibliographic systems. "
10/21/1996 - "The results of the present study suggest that PLG and its two novel analogues are able to modulate dopamine receptor activity and may be possible therapeutic agents for the treatment of Parkinsonian symptoms as well as tardive dyskinesia."
01/01/1992 - "Dopamine receptor abnormalities in the striatum and pallidum in tardive dyskinesia: a post mortem study."
02/01/2015 - "The main emphasis is on movement disorders caused by dopamine receptor-blocking agents. "
|5.||Hypertension (High Blood Pressure)
08/01/2013 - "Upregulation of renal D5 dopamine receptor ameliorates the hypertension in D3 dopamine receptor-deficient mice."
01/01/2012 - "Furthermore, studies in experimental animal models and in humans with salt-sensitive hypertension implicate abnormalities in dopamine receptor regulation because of receptor desensitization resulting from increased GRK4 activity. "
02/01/2003 - "Moreover, recent studies have also demonstrated that the disruption of various dopamine receptor subtypes and their function produces hypertension in rodents. "
08/01/1998 - "Further studies need to be directed toward establishing a direct correlation between defective dopamine receptor gene in the kidney and development of hypertension. "
09/01/1996 - "Thus, selective manipulation of dopamine receptor subtypes might aid in studies of the pathogenesis of essential hypertension and the design of novel drugs to treat high blood pressure."
|1.||Antipsychotic Agents (Antipsychotics)
|2.||Levodopa (L Dopa)
|4.||Dopamine Agonists (Dopamine Agonist)
|8.||Somatostatin (Somatotropin Release-Inhibiting Factor)
|9.||Dopamine Receptors (Dopamine Receptor)
|3.||Drug Therapy (Chemotherapy)
|4.||Self Administration (Administration, Self)